Neeraj Mehta, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1022 1st St N Ste 500, Alabaster, AL 35007 Phone: 205-663-5775 Fax: 205-664-2112 |
Mark Lee Mullens, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1022 1st St N, Suite 500, Alabaster, AL 35007 Phone: 205-663-5775 Fax: 205-664-2112 |
Clyde Dale Elliott, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1022 1st St N, Suite 500, Alabaster, AL 35007 Phone: 205-663-5775 Fax: 205-664-2112 |
John David Mcbrayer, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1022 1st St N, Suite 500, Alabaster, AL 35007 Phone: 205-663-5775 Fax: 205-664-2112 |
Dr. David Steven Fieno, M.D., PH.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1022 1st St N Ste 500, Alabaster, AL 35007 Phone: 205-663-5775 Fax: 205-664-2212 |
Hosakote Nagaraj, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1022 1st St N, Ste 500, Alabaster, AL 35007 Phone: 402-328-4922 |
Clifton Rodgers Vance, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1022 1st St N Ste 500, Alabaster, AL 35007 Phone: 205-663-5775 Fax: 205-664-2112 |
Dr. Krishna Kishore Gaddam, M.D Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1022 1st St N Ste 500, Alabaster, AL 35007 Phone: 205-663-5775 Fax: 205-664-2112 |
Dr. Abilash Rao Balmuri, M.D Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1022 1st St N, Ste 500, Alabaster, AL 35007 Phone: 205-663-5775 Fax: 205-664-2112 |
Raymond N Fernandez, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4198 Us Highway 431, Suite A, Albertville, AL 35950 Phone: 256-891-8580 Fax: 256-891-8581 |
Dr. Joseph Arthur Deering, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1649 Highway 22 W, Alexander City, AL 35010 Phone: 256-215-5323 Fax: 256-215-5324 |
Dr. Basel Alrefai, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 815 Lee St, Alexander City, AL 35010 Phone: 256-212-9300 |
Dr. Kevin Leonard Sublett, M.D.F.A.C.C. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3368 Highway 280, Suite 130, Alexander City, AL 35010 Phone: 256-234-2644 Fax: 256-234-2704 |
Dr. Brian A Foley, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1649 Highway 22 W, Alexander City, AL 35010 Phone: 256-215-5323 Fax: 256-215-5323 |
Gregory D Price Sr., MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 215 Medical Park Dr Ste 1, Andalusia, AL 36420 Phone: 334-222-4327 Fax: 334-222-4333 |
Mohamed Jasser, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 901 Leighton Ave, Suite 307, Anniston, AL 36207 Phone: 256-231-8636 Fax: 256-231-8684 |
Dr. Mohammad Kamran, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1700 Christine Ave, Ste 100, Anniston, AL 36207 Phone: 256-238-1154 Fax: 256-237-8624 |
Judy R. Washington, CRNP Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 171 Town Center Dr, Anniston, AL 36205 Phone: 256-237-1624 Fax: 256-241-2277 |
Dr. John I Nwogu, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 901 Leighton Ave Ste 702, Anniston, AL 36207 Phone: 256-231-2577 Fax: 256-231-2576 |
Arthur Eugene Mays Jr., MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: Nuclear Plant Rd, Nuclear Training Bldng, Athens, AL 35611 Phone: 256-729-2811 Fax: 256-729-2806 |
News Archive
Halozyme Therapeutics, Inc. today announced that it has closed the previously announced $150 million royalty-backed debt transaction with investment funds managed by Pharmakon Advisors and Athyrium Capital Management. The debt is secured by future royalties of ENHANZE products, received only from Halozyme's collaborations with Roche and Baxalta.
Each day, one in seven Coloradans face hunger. It's a serious issue that forces many to choose between putting food on the table and handling day-to-day expenses like paying the bills or purchasing necessary medication. Kaiser Permanente Colorado is reaffirming its commitment to diminishing the rates of hunger in this state by providing 13 local nonprofits a portion of a $1 million grant that aims to increase access to food for all Coloradans.
In a scientific breakthrough, researchers report that they've grown mouse sperm from testicular tissue in the laboratory, a development that could advance the field of infertility in human males. Although still proven in mice, "this is a small but important step in understanding how sperm are formed, which may, in time, lead to us being able to grow human sperm in the laboratory," said Dr. Allan Pacey, senior lecturer in andrology at the University of Sheffield in England, who is familiar with the study results.
New connections between brain cells emerge in clusters in the brain as animals learn to perform a new task, according to a study published in Nature on February 19 (advance online publication). Led by researchers at the University of California, Santa Cruz, the study reveals details of how brain circuits are rewired during the formation of new motor memories.
Biotechnology company Arana Therapeutics Limited today provided an update on the major inflammatory compounds in its drug development pipeline. As part of this update, Arana said it has developed a new antibody candidate ART123, targeting inflammatory diseases and it plans to start a Phase I clinical trial for age-related macular degeneration (AMD) candidate PMX53 in 2009.
› Verified 3 days ago